Dr. Kelli Danielle Bryant, MD

Dr. Bryant practices at Gardens Plastic Surgery in Cape Coral, Florida.

Dr. Bryant's NPI, 1881127108, was assigned on April 4, 2017. Dr. Bryant graduated from Schmidt College of Medicine in 2017. Dr. Bryant holds Florida license ME150529.

Dr. Bryant's primary practice is Gardens Plastic Surgery, at 413 Del Prado S Blvd, Cape Coral, FL 33990 in Lee County. The practice phone is (239) 313-2515.

Dr. Bryant's primary practice is Gardens Plastic Surgery in Cape Coral, Florida. The medical group on file is AQUA Dermatology. Dmand AI also links Dr. Bryant to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bryant practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Bryant's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bryant is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Bryant's licenses on file in 2 states: Florida and Missouri.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, facial skin infection and hives among the conditions Dr. Bryant treats.

CMS data shows 3,806 Medicare services from Dr. Bryant across 20 procedure codes in 2024, for 751 Medicare patients. Medicare paid $158,174 for them. Every service was in an office.

CMS counts 751 Medicare patients who saw Dr. Bryant in 2024. The largest group is 65 to 74, with 417 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bryant's median patient age at 60, with 62% women.

In 2024, Dr. Bryant wrote 826 Medicare Part D claims for 426 patients. 94% of them were for generic drugs. CMS names the drug for 726 of them, across 15 drugs with 11 or more claims each, at $59,740 in total drug cost. In 2023, CMS named 671 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bryant for performance year 2024, reported as part of a group. Dr. Bryant accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,240 procedures of removal of skin lesions by Dr. Bryant, more than 95% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Bryant in 2016. Dr. Bryant's most frequent co-authors are Matthew Jordan Denunzio, MD and Michael John Ford, MD.

CMS Open Payments shows 559 general payments to Dr. Bryant from 27 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 94% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $2,080.

Dr. Bryant graduated from Schmidt College of Medicine in 2017.

Dr. Bryant is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.